Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

143.72
-1.0900-0.75%
Post-market: 143.58-0.1428-0.10%19:30 EDT
Volume:4.20M
Turnover:605.07M
Market Cap:178.31B
PE:-54.96
High:145.99
Open:145.24
Low:143.50
Close:144.81
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.77
T/O Rate:0.34%
Dividend:3.22
Dividend Rate:2.24%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.07
PE(LYR):21.20

Loading ...

Barclays Adjusts Gilead Sciences Price Target to $145 From $155, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Gilead Sciences is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 28

Gilead price target lowered to $165 from $166 at Morgan Stanley

TIPRANKS
·
Jul 27

Gilead Sciences (GILD) Gets a Hold from RBC Capital

TIPRANKS
·
Jul 25

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Moderna Inc. Stock Falls 5.2%, Underperforms Peers

Dow Jones
·
Jul 25

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

EMA CHMP Backs Gilead Trodelvy-keytruda Combo for First-line Pd-l1+ Metastatic TNBC

Reuters
·
Jul 24

Chmp Recommends Gilead’s Trodelvy® Plus Keytruda® in Pd-(l)1-positive First-line Metastatic Triple-negative Breast Cancer

THOMSON REUTERS
·
Jul 24

Ema's Chmp: Recommends Granting Marketing Authorisation for Icotyde

THOMSON REUTERS
·
Jul 24

Leerink Partners Adjusts Gilead Sciences Price Target to $126 From $127, Maintains Market Perform Rating

MT Newswires Live
·
Jul 23

U.S. Research Roundup-alphabet, IBM, Tesla

Reuters
·
Jul 23

Gilead : Leerink Partners Cuts Target Price to $126 from $127

THOMSON REUTERS
·
Jul 23

Gilead Bdrs Undergo 5-for-1 Stock Split as Ratio Shifts to 1:12

Reuters
·
Jul 22

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Gilead Sciences (GILD) Gets a Hold from Goldman Sachs

TIPRANKS
·
Jul 22

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 22

Gilead to Report Q2 2026 Results After Market Close, Host Webcast Update

Reuters
·
Jul 22

Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

THOMSON REUTERS
·
Jul 22